Comparison of tenofovir and entecavir in patients with chronic HBV infection

CEYLAN B., YARDIMCI C., FINCANCI M., EREN G., TOZALGAN U., MUDERRISOGLU C., ...More

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, vol.17, no.18, pp.2467-2473, 2013 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 17 Issue: 18
  • Publication Date: 2013
  • Journal Name: EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.2467-2473
  • Keywords: Entecavir, Tenofovir, Hepatitis B virus, CHRONIC HEPATITIS-B, DISOPROXIL-FUMARATE, E-ANTIGEN, NUCLEOSIDE-NAIVE, EFFICACY, VIRUS, LAMIVUDINE, ADEFOVIR, SAFETY
  • Bezmialem Vakıf University Affiliated: Yes

Abstract

BACKGROUND: Sustained suppression of serum HBV DNA levels with nucleos(t)ide analogues is the most important success obtained in the treatment of chronic HBV infection today. Tenofovir and entecavir provide more robust viral suppression.